Clinical Trial

A Randomized, Double-blind Clinical Trial on the Efficacy of a Dietary Formulation Containing Medium-chain Triglycerides (MCT) and Fiber in Patients With Psoriatic Arthritis

Study acronym: CALIPSO
Completed
View on ClinicalTrials.gov →
Summary
The primary objective of this study is to evaluate the effects of a formulation containing medium-chain triglycerides (MCTs) and vegetable fibers on the quality of life of patients with psoriatic arthritis, by monitoring the patients over a period of 3 months in a single-center interventional study. As secondary objectives, the study will assess the effects of the same formulation on disease activity and on certain blood parameters and dietary habits.
Protocol Amendment History 2 amendments
This ClinicalTrials.gov record has been amended 2 times since 2025-05-16; most recent amendment 2026-04-17.
Status change: Recruiting → Completed 2026-04-17
Status change: Not Yet Recruiting → Recruiting 2025-05-28
Trial Details
NCT Number NCT06990152
Lead Sponsor Dr. Schär AG / SPA
Collaborators: ASST Gaetano Pini-CTO
Conditions Psoriatic Arthritis (PsA)
Enrollment 72 participants
Start Date 2025-05-16
Primary Completion 2026-02-28 (estimated)
Study Completion 2026-02-28 (estimated)
Updated on ClinicalTrials.gov 2026-04-20